Table 3.
MLHFQ total score | EQ‐5D‐3L health score | KCCQ overall score | |
---|---|---|---|
Age | −0.164 | 0.110 | 0.095 |
Gender | 0.078 | 0.025 | −0.069 |
NYHA class | 0.588** | −0.436** | −0.613** |
BMI | −0.019 | −0.110 | −0.008 |
LVEF | −0.172* | −0.095 | 0.074 |
Systolic BP | −0.065 | −0.001 | 0.079 |
Heart rate | 0.111 | −0.138 | −0.174* |
eGFR | 0.058 | −0.083 | −0.030 |
BNP | 0.069 | 0.083 | −0.071 |
Co‐morbidities | 0.036 | −0.040 | −0.088 |
BMI, body mass index (kg/m2); BNP, B‐type natriuretic peptide; BP, blood pressure; eGFR, estimated glomerular filtration rate; EQ‐5D‐3L, EuroQoL 5D‐3L; KCCQ, Kansas City Cardiomyopathy Questionnaire; LVEF, left ventricular ejection fraction; MLHFQ, Minnesota Living with Heart Failure Questionnaire; NYHA, New York Heart Association; QoL, quality of life.
Correlation is significant at the 0.05 level (two‐tailed).
Correlation is significant at the 0.01 level (two‐tailed).